Analysis of immune response against cancer, which may lead to establishment of WT1 peptide-based immunotherapy for the conventional treatment-resistant malignancies in the respiratory medicine field
Analysis of immune response against cancer, which may lead to establishment of WT1 peptide-based immunotherapy for the conventional treatment-resistant malignancies in the respiratory medicine field
批准号:
15K09173
负责人:
OKA YOSHIHIRO
金额:
$3.0万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2015
资助国家:
日本
项目状态:
已结题
起止时间:
2015-04-01 至 2018-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
WT1 peptide IgG autoantibody: a predictive marker for WT1 peptide-based immunotherapy for glioblastoma.
WT1 肽 IgG 自身抗体:基于 WT1 肽的胶质母细胞瘤免疫治疗的预测标记。
DOI:
--
发表时间:
2015
期刊:
影响因子:
--
作者:
[岩井美樹, 尾路祐介, 村上由衣, 橋本直哉, 坪井昭博, 保仙直樹, 西田純幸, 中田 潤, 中島博子, 岡 芳弘, 吉峰俊樹, 杉山治夫]
通讯作者:
杉山治夫
DOI:
10.1002/ijc.30182
发表时间:
2016-09-15
期刊:
INTERNATIONAL JOURNAL OF CANCER
影响因子:
6.4
作者:
[Oji, Yusuke, Hashimoto, Naoya, Tsuboi, Akihiro, Murakami, Yui, Iwai, Miki, Kagawa, Naoki, Chiba, Yasuyoshi, Izumoto, Shuichi, Elisseeva, Olga, Ichinohasama, Ryo, Sakamoto, Junichi, Morita, Satoshi, Nakajima, Hiroko, Takashima, Satoshi, Nakae, Yoshiki, Nakata, Jun, Kawakami, Manabu, Nishida, Sumiyuki, Hosen, Naoki, Fujiki, Fumihiro, Morimoto, Soyoko, Adachi, Mayuko, Iwamoto, Masahiro, Oka, Yoshihiro, Yoshimine, Toshiki, Sugiyama, Haruo]
通讯作者:
Sugiyama, Haruo
An open-label phase II randomized trial of WI1 peptide vaccine plus gemcitabine for advanced pancreatic cancer.
WI1 肽疫苗加吉西他滨治疗晚期胰腺癌的开放标签 II 期随机试验。
DOI:
--
发表时间:
2016
期刊:
影响因子:
--
作者:
[Ishikawa T., Nishida S., Egawa S., Koido S., Ishii J., Kanno Y., Yanagimoto H., Kokura S., Morimoto S., Oba M.S., Oka Y., Sugiyama H.]
通讯作者:
Sugiyama H.
An essential role of the avidity of T-cell receptor in differentiation of self-antigen-reactive CD8+ T cells
T 细胞受体的亲和力在自身抗原反应性 CD8 T 细胞分化中的重要作用
DOI:
10.1097/cji.0000000000000114
发表时间:
2016
期刊:
Journal of Immunotherapy
影响因子:
3.9
作者:
[Kondo K, Fujiki F, Nakajima H, Yatsukawa E, Morimoto S, Tatsumi N, Nishida S, Nakata J, Oka Y, Tsuboi A, Hosen N, Oji Y, Sugiyama H]
通讯作者:
Sugiyama H
DOI:
10.1002/ijc.31253
发表时间:
2018-06-01
期刊:
INTERNATIONAL JOURNAL OF CANCER
影响因子:
6.4
作者:
[Oji, Yusuke, Inoue, Masayoshi, Sugiyama, Haruo]
通讯作者:
Sugiyama, Haruo
共 11 条
海外基金